Gyre Therapeutics's total assets for Q3 2024 were $125.24M, an increase of 3.56% from the previous quarter. GYRE total liabilities were $26.77M for the fiscal quarter, a -2.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.